SCHEMBL23969672

SCHEMBL23969672

Fc1cc(-c2ccccc2)ccc1CI

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 1/20 0.38
CHRM5 P08912 1/20 0.38
ALOX5 P09917 1/20 0.38
FFAR1 O14842 1/20 0.37
TAAR1 Q96RJ0 2/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
DCLRE1A Q6PJP8 1/20 0.36
DCLRE1B Q9H816 1/20 0.36
CYP19A1 P11511 2/20 0.35
GBA1 P04062 2/20 0.35
LCT P09848 2/20 0.35
UGCG Q16739 2/20 0.35
GBA2 Q9HCG7 2/20 0.35
MGAM O43451 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168537 0.80 ALDH1A1 (0.43) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL29064768 0.80 KIF11 (0.43) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL17859649 0.80 FFAR1 (0.43) CYP11B1CYP11B2CHRM5FFAR1AKR1C2
SCHEMBL2574818 0.80 TAAR1 (0.48) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL30083378 0.80 TAAR1 (0.48) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL8164059 0.77 HSD17B1 (0.41) CYP11B1CYP11B2HSD17B1HSD17B2CHRM5
SCHEMBL8167859 0.77 ALDH1A1 (0.40) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL458899 0.77 RARB (0.41) CYP11B1CYP11B2HSD17B1HSD17B2ALDH1A1
SCHEMBL17281581 0.76 SMN1; SMN2 (0.41) HSD17B1HSD17B2ALDH1A1ALOX5
SCHEMBL538898 0.76 PTGS1 (0.53) FFAR1AKR1C2AKR1C1DCLRE1ADCLRE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3904366-A1 END CAPPED NUCLEIC ACID MOLECULES Novartis AG (CH) 2021-11-03 EP disclosed